With the highest attending rate of TTOs, research institutes and academia together with big pharma, emerging and small biotech, diagnostics companies, pre-seed / seed / Series A investors, BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovations in the field of Life Sciences. BioFIT is also becoming the European marketplace for seed investment in Life Sciences.
WHY ATTEND BIOFIT?
Out of 1,000 BioFIT attendees, 1,000 deals have been generated. The breakdown in terms of nature of deals is the following:
- 35% of collaborative research projects
- 30% of licensing deals
- 15% of equity investment deals
- 20% of services deals
Estimate based on the measurement of 2015 and 2016 delegates’ outcomes
- 1,000+ delegates
- 30 countries represented
- 2,700 one-to-one meetings scheduled
- 1,000 licensing opportunities
BIA members receive 25% off early bird rate, 15% off regular rate. Email us for your discount code.
*Present your project in front of pharma, biotech companies, TTOs and VCs and find partners who share your vision*
The call for applications for the Start-up Slams is free of charge and open to all innovative start-up companies (less than 5 years old) having an innovative therapeutic product.